These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 17595771)

  • 1. Epidermal growth factor receptor (EGFR) mutation does not correlate with platinum resistance in ovarian carcinoma. Results of a prospective pilot study.
    Mustea A; Sehouli J; Fabjani G; Koensgen D; Möbus V; Braicu EI; Pirvulescu C; Thomas A; Tong D; Zeillinger R
    Anticancer Res; 2007; 27(3B):1527-30. PubMed ID: 17595771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor structural alterations in gastric cancer.
    Moutinho C; Mateus AR; Milanezi F; Carneiro F; Seruca R; Suriano G
    BMC Cancer; 2008 Jan; 8():10. PubMed ID: 18199332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Searching for a magic bullet in NSCLC: the role of epidermal growth factor receptor mutations and tyrosine kinase inhibitors.
    Wong KK
    Lung Cancer; 2008 Jun; 60 Suppl 2():S10-8. PubMed ID: 18513579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations of epidermal growth factor receptor in colorectal carcinoma.
    Nagahara H; Mimori K; Ohta M; Utsunomiya T; Inoue H; Barnard GF; Ohira M; Hirakawa K; Mori M
    Clin Cancer Res; 2005 Feb; 11(4):1368-71. PubMed ID: 15746034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines.
    Liu W; Wu X; Zhang W; Montenegro RC; Fackenthal DL; Spitz JA; Huff LM; Innocenti F; Das S; Cook EH; Cox NJ; Bates SE; Ratain MJ
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6788-95. PubMed ID: 18006781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor (EGFR) is highly conserved in pancreatic cancer.
    Tzeng CW; Frolov A; Frolova N; Jhala NC; Howard JH; Buchsbaum DJ; Vickers SM; Heslin MJ; Arnoletti JP
    Surgery; 2007 Apr; 141(4):464-9. PubMed ID: 17383523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR FISH versus mutation: different tests, different end-points.
    Cappuzzo F
    Lung Cancer; 2008 May; 60(2):160-5. PubMed ID: 18367287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.
    Kancha RK; von Bubnoff N; Peschel C; Duyster J
    Clin Cancer Res; 2009 Jan; 15(2):460-7. PubMed ID: 19147750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer.
    Fukui T; Ohe Y; Tsuta K; Furuta K; Sakamoto H; Takano T; Nokihara H; Yamamoto N; Sekine I; Kunitoh H; Asamura H; Tsuchida T; Kaneko M; Kusumoto M; Yamamoto S; Yoshida T; Tamura T
    Clin Cancer Res; 2008 Aug; 14(15):4751-7. PubMed ID: 18676744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma.
    Foster JM; Gatalica Z; Lilleberg S; Haynatzki G; Loggie BW
    Ann Surg Oncol; 2009 Jan; 16(1):152-8. PubMed ID: 18998063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of EGFR mutation analysis in non-small cell lung cancer.
    Yamamoto H; Toyooka S; Mitsudomi T
    Lung Cancer; 2009 Mar; 63(3):315-21. PubMed ID: 18760859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
    Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients.
    Yung TK; Chan KC; Mok TS; Tong J; To KF; Lo YM
    Clin Cancer Res; 2009 Mar; 15(6):2076-84. PubMed ID: 19276259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status.
    Pesek M; Benesova L; Belsanova B; Mukensnabl P; Bruha F; Minarik M
    Anticancer Res; 2009 Jul; 29(7):2767-73. PubMed ID: 19596959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
    Lee KH; Min HS; Han SW; Oh DY; Lee SH; Kim DW; Im SA; Chung DH; Kim YT; Kim TY; Heo DS; Bang YJ; Sung SW; Kim JH
    Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors.
    John T; Liu G; Tsao MS
    Oncogene; 2009 Aug; 28 Suppl 1():S14-23. PubMed ID: 19680292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of G2607A mutation in EGFR gene with a significative rate in Moroccan patients with nasopharyngeal carcinoma.
    Naji F; Attaleb M; Laantri N; Benchakroun N; El Gueddari B; Benider A; Azeddoug H; Ennaji MM; El Mzibri M; Khyatti M
    Cell Mol Biol (Noisy-le-grand); 2010 Dec; 56 Suppl():OL1442-6. PubMed ID: 21215239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer.
    Psyrri A; Kassar M; Yu Z; Bamias A; Weinberger PM; Markakis S; Kowalski D; Camp RL; Rimm DL; Dimopoulos MA
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8637-43. PubMed ID: 16361548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR mutational status in penile cancer.
    Di Lorenzo G; Buonerba C; Gaudioso G; Gigantino V; Quarto G; De Domenico R; Caraglia M; Di Trolio R; Ascierto PA; De Placido S; Perdonà S; Franco R
    Expert Opin Ther Targets; 2013 May; 17(5):501-5. PubMed ID: 23517177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.